Evolution of the Primate Brain


Book Description

This volume of Progress in Brain Research provides a synthetic source of information about state-of-the-art research that has important implications for the evolution of the brain and cognition in primates, including humans. This topic requires input from a variety of fields that are developing at an unprecedented pace: genetics, developmental neurobiology, comparative and functional neuroanatomy (at gross and microanatomical levels), quantitative neurobiology related to scaling factors that constrain brain organization and evolution, primate palaeontology (including paleoneurology), paleo-anthropology, comparative psychology, and behavioural evolutionary biology. Written by internationally-renowned scientists, this timely volume will be of wide interest to students, scholars, science journalists, and a variety of experts who are interested in keeping track of the discoveries that are rapidly emerging about the evolution of the brain and cognition. Written by internationally renowned scientists, this timely volume will be of wide interest to students, scholars, science journalists, and a variety of experts who are interested in keeping track of the discoveries that are rapidly emerging about the evolution of the brain and cognition




Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques


Book Description

Volume 45 of "Progress in Drug Research" contains eight reviews and the various indexes which facilitate its use and establish the connection with the previous volumes. The articles in this volume deal with neuro peptides as native immune modulators, with Calmodulin and with effects of cell stimuli and drugs on cellular activation, with recent advances in benzodiazepine receptor binding studies, with the medicinal chemistry and therapeutic potentials of ligands of the histamine H3 receptor, with Serotonin uptake inhibitors, with computer-aided drug design, with natri uretic hormones and with the recent developments in the chemotherapy of osteoporosis. In the 36 years that PDR has existed, the Editor has enjoyed the valu able help and advice of many colleagues. Readers, the authors of the reviews and, last but not least, the reviewers have all contributed greatly to the success of this series. Although the comments received so far have generally been favorable, it is nevertheless necessary to analyze and to reassess the current position and the future direction of such a series of monographs. So far, it has been the Editor's intention to help disseminate information on the vast domain of drug research, and to provide the reader with a tool with which to keep abreast of the latest developments and trends. The reviews in PDR are useful to the nonspecialist, who can obtain an overview of a particular field of drug research in a relatively short time.







Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques


Book Description

Today's drug research is an extremely complex process which, apart from chemistry, pharmacology, toxicology and preclinical trials, in cludes a variety of sciences such as biotechnology, biochemistry, im munology, physics, biology and even computer sciences. The Table of Contents of the present volume demonstrates this situation and makes it evident that the individual researcher cannot possibly hope to keep abreast of all aspects of modern drug research. In this re spect, the series of monographs "Progress in Drug Research" pro vides valuable help and assistance. Those who simply wish to remain informed of the latest trends and developments in drug research can use the 34 volumes so far available as a source of almost encyclo pedic character. Researchers actively engaged in the various scientific fields forming the entity of drug research can benefit from the wealth of knowledge and experience of the respective authors, and they will be assisted in their endeavour to discover new pharmaceutical agents. Moreover, the extensive bibliographies of the individual reviews provide an invaluable overview of the literature most pertinent to today's drug research. I should like to thank all the authors for their willingness to prepare the reviews and for sharing their insights and experience with the readers. Thanks are also due to Mrs L. Koechlin, H.-P. Thiir and A. Gomm of Birkhauser Publishers for their valuable help in the pre paration of this volume.




Progress in Drug Research


Book Description







Recent Progress in Hormone Research


Book Description

Recent Progress in Hormone Research, Volume 46 provides a superior summary of the developments in the field of hormone research. The book discusses the molecular basis of androgen insensitivity; the tissue-specific expression of the growth hormone gene and its control by growth hormone factor-1; and the molecular characterization of mammalian tachykinin receptors and a possible epithelial potassium channel. The text also describes the properties of the guanylate cyclase receptor family; insulin-like growth factor-binding proteins; and growth hormone receptor and binding protein. Mutations in the insulin receptor gene in genetic forms of insulin resistance; the characteristics of the cAMP response unit; and the role and secretion of inhibin in the rat are also considered. The book further tackles the structure of the lutropin/choriogonadotropin receptor and the gene for multiple endocrine neoplasia type 2a. Endocrinologists, physiologists, and biochemists will find the text invaluable.




Advances in Cholesterol Research


Book Description

Advances in Cholesterol Research presents a range of topics which, for the most part, have not been reviewed in recent years in books published on cholesterol. The subject area can be divided into two main sections. The intracellular and extracellular dynamics of cholesterol. The intracellular dynamics of cholesterol includes the intracellular distributions of cholesterol, cellular functions of the sterol, cholesterol metabolism in steroidogenic tissues, the cholestryl ester cycle, relation between cholesterol and dolichol biosynthesis, and the role of cholesterol in tumor cell proliferation. The section on extracellular dynamics of cholesterol includes the biogenesis of high density lipoprotein subclasses, structure-function relation in lecithin: cholesterol acyltransferase, and the role of cholesterol in atherosclerosis and in membrane fusion.




Research Advances in the Compositae


Book Description

T. J. MABRY and G. W AGENITZ The half-day symposium on "Multidisciplinary approaches to the systematics of Compositae", held as part of the XIV International Botanical Congress in Berlin, on July 26, 1987, was designed to complement the University of Reading Compositae Conference (1975). The latter had yielded two impressive and thorough volumes on "The biology and chemistry of the Compositae", which were edited by HEYWOOD, HARBORNE & TURNER (1977). The 1987 Berlin Symposium did not attempt to update the information from the earlier conference but instead focussed on selected new methods for investigating the systematics of the family as well as a few examples of new systematic approaches with classical methods. From mapping chloroplast DNA restriction sites JANSEN, PALMER, and MI CHAELS reported the astonishing fact that, with the exception of one group (the subtribe Barnadesiinae of the tribe Mutisieae), all investigated other members of Compositae exhibit a characteristic inversion in their chloroplast DNA, suggesting that the inversion occurred early in the evolution of the family and that at least its major part is monophyletic. Within those groups with the inverted segment, chloroplast DNA also suggests that most of the conventionally recognized tribes are also monophyletic. This lends high credit to our predecessors who laid the foundations for the taxonomic system of the Compositae. These chloroplast DNA studies have already been published and are not included here (JANSEN & PALMER 1987, 1988).




Advances in Drug Research


Book Description

This volume continues the trend for Advances in Drug Research of shorter, but more frequent volumes. In line with the tradition of the series, chapters on general themes are interspersed with chapters on specific drug classes and targets. It will be the last volume edited by Bernard Testa and Urs A. Meyer.